An End to That $80 Billion Pharma Deal?

So writes The New York Times, reporting today that the nation’s drug makers are prepping to pay more, under the Democrats’ final health reform bill, than the $80 billion they volunteered in an agreement made with some Democrats earlier in the year.

As the health care bills move

More…

These Are the Guys the White House Cut a Deal With?

Via The Wall Street Journal, here’s the inane argument being tried by Merck, the pharmaceutical giant that defended itself before the Supreme Court this week against investors suing over the company’s failure to concede the risks of Vioxx before 2004, when the popular arthritis drug was More…